tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SAGE Stock Latest News

Sage Therapeutics price target lowered to $8.50 from $11 at JPMorgan
The FlySage Therapeutics price target lowered to $8.50 from $11 at JPMorgan
6d ago
SAGE
Avidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts
PremiumWeekend Updates
Avidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts
7d ago
RNA
ALKS
Sage Therapeutics price target raised to $9 from $7 at Baird
PremiumThe Fly
Sage Therapeutics price target raised to $9 from $7 at Baird
8d ago
SAGE
H.C. Wainwright sees potential competition for Sage from Biogen
PremiumThe Fly
H.C. Wainwright sees potential competition for Sage from Biogen
11d ago
BIIB
SAGE
Sage Therapeutics price target raised to $9 from $8 at Truist
PremiumThe Fly
Sage Therapeutics price target raised to $9 from $8 at Truist
11d ago
SAGE
SUPN
Hold Rating on SAGE Therapeutics Amid Uncertainty and Acquisition Developments
PremiumRatingsHold Rating on SAGE Therapeutics Amid Uncertainty and Acquisition Developments
11d ago
SAGE
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
Premium
The Fly
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
11d ago
BIIB
SAGE
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
Premium
The Fly
Sage Therapeutics price target raised to $8.50 from $8 at Canaccord
11d ago
BIIB
SAGE
Hold Rating on SAGE Therapeutics Amid Acquisition Offer and CVR Uncertainties
PremiumRatings
Hold Rating on SAGE Therapeutics Amid Acquisition Offer and CVR Uncertainties
11d ago
SAGE
Sage Therapeutics moved to No Rating at BofA
PremiumThe Fly
Sage Therapeutics moved to No Rating at BofA
11d ago
SAGE
Sage Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Sage Therapeutics downgraded to Neutral from Overweight at Piper Sandler
12d ago
SAGE
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
PremiumThe Fly
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
12d ago
BA
BMY
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
PremiumThe FlyMorning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
12d ago
X
AMZN
Video: Sarepta, Hinge Health among major pre-market movers
Premium
The Fly
Video: Sarepta, Hinge Health among major pre-market movers
12d ago
HNGE
INCY
SAGE Therapeutics Announces Merger with Supernus Pharmaceuticals
Premium
Company Announcements
SAGE Therapeutics Announces Merger with Supernus Pharmaceuticals
12d ago
8K
SAGE
Supernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
PremiumThe Fly
Supernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
12d ago
BIIB
SAGE
Supernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
PremiumThe Fly
Supernus to acquire Sage Therapeutics for $8.50 per share in cash plus CVR
12d ago
SAGE
SUPN
SAGE Therapeutics Approves Stock Plan Amendment
PremiumCompany Announcements
SAGE Therapeutics Approves Stock Plan Amendment
15d ago
8K
SAGE
SAGE Therapeutics: Hold Rating Maintained Amid Steady Growth and Strategic Uncertainties
PremiumRatings
SAGE Therapeutics: Hold Rating Maintained Amid Steady Growth and Strategic Uncertainties
2M ago
SAGE
Sage Therapeutics’ Earnings Call Highlights Growth and Uncertainty
PremiumCompany AnnouncementsSage Therapeutics’ Earnings Call Highlights Growth and Uncertainty
2M ago
SAGE
SAGE Therapeutics: Hold Rating Amid Uncertainty in Sales Growth and Strategic Developments
Premium
Ratings
SAGE Therapeutics: Hold Rating Amid Uncertainty in Sales Growth and Strategic Developments
2M ago
SAGE
Cautious Hold Rating on SAGE Therapeutics Amid Uncertain Growth Prospects
Premium
Ratings
Cautious Hold Rating on SAGE Therapeutics Amid Uncertain Growth Prospects
2M ago
SAGE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >